Syra Health Corp. SYRA
$0.91
$0.022.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.09M | 7.64M | 7.23M | 7.50M | 8.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.09M | 7.64M | 7.23M | 7.50M | 8.06M |
| Cost of Revenue | 4.91M | 4.77M | 4.74M | 5.27M | 5.72M |
| Gross Profit | 3.18M | 2.87M | 2.49M | 2.23M | 2.35M |
| SG&A Expenses | 3.04M | 3.06M | 3.30M | 3.41M | 3.67M |
| Depreciation & Amortization | 9.50K | 14.80K | 20.50K | 25.50K | 45.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.02M | 7.88M | 8.13M | 8.77M | 9.53M |
| Operating Income | 74.70K | -240.10K | -904.40K | -1.27M | -1.47M |
| Income Before Tax | 130.70K | -183.10K | -896.40K | -1.27M | -1.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.13 | -0.18 | -0.90 | -1.27 | -1.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 130.70K | -183.10K | -896.40K | -1.27M | -1.46M |
| EBIT | 74.70K | -240.10K | -904.40K | -1.27M | -1.47M |
| EBITDA | 98.20K | -106.00K | -764.50K | -1.13M | -1.31M |
| EPS Basic | 0.01 | -0.02 | -0.08 | -0.12 | -0.15 |
| Normalized Basic EPS | 0.01 | -0.01 | -0.05 | -0.07 | -0.10 |
| EPS Diluted | 0.01 | -0.02 | -0.08 | -0.12 | -0.16 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.05 | -0.07 | -0.10 |
| Average Basic Shares Outstanding | 48.99M | 47.76M | 47.41M | 45.30M | 40.63M |
| Average Diluted Shares Outstanding | 50.21M | 48.60M | 47.41M | 45.30M | 40.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |